H. PYLORI INFECTION TREATMENT GUIDELINE | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Is patient allergic to penicillin? | ||||||||||||||||||||||
No | Yes | |||||||||||||||||||||
▼ | ▼ | |||||||||||||||||||||
• Bismuth quadruple • Levofloxacin triple • Levofloxacin sequential |
◄ | Yes1 |
Does patient have previous macrolide exposure? |
Does patient have previous macrolide exposure? |
Yes1 |
► | Bismuth quadruple | |||||||||||||||
No | No | |||||||||||||||||||||
▼ | ▼ | |||||||||||||||||||||
Recommended • Bismuth quadruple • Concomitant • Clarithromycin triple with amoxicillin |
Other options • Sequential • Hybrid • Levofloxacin triple • Levofloxacin sequential |
• Clarithromycin triple with metronidazole • Bismuth quadruple |
||||||||||||||||||||
FIRST-LINE THERAPIES | ||||||||||||||||||||||
Regimen | Drugs/Dosing | Duration (days) | ||||||||||||||||||||
RECOMMENDED | ||||||||||||||||||||||
Clarithromycin triple2 |
PPI (standard or double dose twice daily) + clarithromycin (500mg twice daily) + amoxicillin (1g twice daily) OR metronidazole (500mg three times daily) |
14 |
||||||||||||||||||||
Bismuth quadruple3 |
PPI (standard dose twice daily) + bismuth subcitrate (120–300mg 4 times daily) or subsalicylate (300mg 4 times daily) + tetracycline (500mg 4 times daily) + metronidazole (250mg 4 times daily or 500mg 3–4 times daily) |
10 –14 |
||||||||||||||||||||
Concomitant4 |
PPI (standard dose twice daily) + clarithromycin (500mg twice daily) + amoxicillin (1g twice daily) + nitroimidazole5 (500mg twice daily) |
10 –14 |
||||||||||||||||||||
SUGGESTED | ||||||||||||||||||||||
Sequential4 |
PPI (standard dose twice daily) + amoxicillin (1g twice daily) THEN |
5 –7 |
||||||||||||||||||||
PPI + clarithromycin (500mg twice daily) + nitroimidazole5 (500mg twice daily) |
5 –7 |
|||||||||||||||||||||
Hybrid4 |
PPI (standard dose twice daily) + amoxicillin (1g twice daily) THEN |
7 |
||||||||||||||||||||
PPI + amoxicillin + clarithromycin (500mg twice daily) + nitroimidazole5 |
7 |
|||||||||||||||||||||
Levofloxacin triple4 |
PPI (standard dose twice daily) + levofloxacin (500mg daily) + amoxicillin |
10 –14 |
||||||||||||||||||||
Levofloxacin sequential4 |
PPI (standard or double dose twice daily) + amoxicillin (1g twice daily) THEN |
5 –7 |
||||||||||||||||||||
PPI + levofloxacin (500mg daily) + nitroimidazole5 (500mg twice daily) |
5 –7 |
|||||||||||||||||||||
LOAD4 |
Levofloxacin (250mg daily) + omeprazole (double dose daily) + nitazoxanide (500mg twice daily) + doxycycline (100mg daily) |
7 –10 |
||||||||||||||||||||
NOTES | ||||||||||||||||||||||
Key: PPI = proton pump inhibitor; LOAD = levofloxacin + omeprazole + Alinia + doxycycline 1 Includes patients in regions where clarithromycin resistance is known to be >15%. 2 Several PPIs (eg, Prilosec, Nexium, Prevacid, Aciphex) in combination with clarithromycin and amoxicillin have achieved FDA approval. FDA-approved combination products include Omeclamox-Pak (omeprazole/amoxicillin/clarithromycin) and Prevpac (lansoprazole/amoxicillin/clarithromycin). PPI + clarithromycin + metronidazole is not an FDA-approved regimen. 3 Not an FDA-approved regimen if prescribed separately. Pylera (bismuth subcitrate/tetracycline/metronidazole) combined with omeprazole for 10 days is FDA-approved. 4 Not an FDA-approved regimen. 5 Metronidazole or tinidazole. For FDA-approved regimens, see drug monographs at www.eMPR.com or contact company for full drug labeling. |
||||||||||||||||||||||
REFERENCES | ||||||||||||||||||||||
Chey WD, Leontiadis GI, Howde CW, et al. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. (Rev. 3/2018) |
Please login or register first to view this content.